CME and CFTC Clash Over On-Chain Perpetual Futures

The CME Group, the largest derivatives exchange operator in the U.S., is engaged in a heated battle with its regulator, the Commodity Futures Trading Commission (CFTC), over the introduction of blockchain-based perpetual future products. The CFTC's decision to allow the listing of crypto perpetual futures, also known as perps, has been met with resistance from the CME, which claims that these products are harmful to its traditional futures contracts and that the regulator is mislabeling them. The CME has filed a lawsuit against the CFTC, arguing that perps are swaps, which require an end date, and that the regulator's sudden embrace of them did not consider the ramifications. The dispute has significant implications for the rapidly growing market of perpetual futures, with non-U.S. perps volume reportedly reaching $60 trillion in volume last year. The CFTC's chairman, Mike Selig, has defended the regulator's decision, stating that it is appropriate to allow the listing of perps, while the CME's chairman, Terry Duffy, has expressed concerns about the impact on traditional futures contracts and the lack of clarity around the regulation of perps. The disagreement has sparked a wider debate about the role of regulators in the development of new financial products and the need for clear and consistent rules to govern the market. As the legal battle between the CME and CFTC unfolds, market participants are watching closely, with some arguing that the regulator's approach is too hasty and others seeing it as a necessary step to allow for innovation and competition in the market.